Transcription-targeted gene therapy for androgen-independent prostate cancer. - Wikidata - awgldk - TriplyDB

Transcription-targeted gene therapy for androgen-independent prostate cancer.

Transcription-targeted gene therapy for androgen-independent prostate cancer.

http://www.wikidata.org/entity/Q43169344

about

Baculoviruses as Vectors for Gene Therapy against Human Prostate Cancer Transcriptional Targeting in Cancer Gene Therapy IL-18 inhibits growth of murine orthotopic prostate carcinomas via both adaptive and innate immune mechanisms Small RNA- and DNA-based gene therapy for the treatment of liver cirrhosis, where we are?Cancer gene therapy: an awkward adolescence.Gene therapy and immunotherapy of prostate cancer: adenoviral-based strategies.Genetically engineered murine models of prostate cancer: insights into mechanisms of tumorigenesis and potential utility.Novel gene-directed enzyme prodrug therapies against prostate cancer.Recent patents on therapeutic applications of the transcription factor decoy approach.Preclinical evaluation of a prostate-targeted gene-directed enzyme prodrug therapy delivered by ovine atadenovirus.Activity of the matrix metalloproteinase-9 promoter in human normal and tumor cells.Improved gene transfer selectivity to hepatocarcinoma cells by retrovirus vector displaying single-chain variable fragment antibody against c-Met.Targeting strategies of adenovirus‑mediated gene therapy and virotherapy for prostate cancer (Review).

P2860

Q24790974-BB672AF2-4180-4BAE-B958-92C65F0DD556 Q24791038-A899BD21-53AF-4D06-B0AA-D25AD5167B96 Q34026026-C3FBFE30-2AA2-469E-BB22-433EBFEC2331 Q34405044-2926C694-73AE-442C-AA6F-10888CBD2462 Q35165726-C2F9E07D-2555-4BDC-863D-05BAC7E0C475 Q36258513-83384CCF-EE87-4A86-81AB-1820376CC918 Q36429488-44A6A565-C11A-41D6-A083-0D1206692A47 Q36543076-AF523713-3CB1-468C-9D8A-4ACF506118DB Q37948111-40932D6D-3D7D-40E8-94D1-A435E782F655 Q40519641-5DEAEAA8-93B3-437F-95DD-A709F484DD67 Q40586923-27084E2C-BF68-42B9-BBE4-4D206C07CD8B Q45870062-1C4F08C1-9D5F-4DEC-A591-CCD847C8CB6A Q45871873-9B712BAB-D7DB-4160-9380-620838863D41

P2860

Transcription-targeted gene therapy for androgen-independent prostate cancer.

http://www.wikidata.org/entity/Q43169344

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Transcription-targeted gene therapy for androgen-independent prostate cancer.

@en

Transcription-targeted gene therapy for androgen-independent prostate cancer.

@nl

type

label

Transcription-targeted gene therapy for androgen-independent prostate cancer.

@en

Transcription-targeted gene therapy for androgen-independent prostate cancer.

@nl

prefLabel

Transcription-targeted gene therapy for androgen-independent prostate cancer.

@en

Transcription-targeted gene therapy for androgen-independent prostate cancer.

@nl

P1433

Q43169344-23DDFE32-650F-4A77-9F1A-673AFB30D631

P1476

Q43169344-7E350427-AA7E-4384-BB81-E5B6B02827F0

P2093

Q43169344-0A7F1BB0-755A-4011-9EBB-2298D5AA4445

Q43169344-3AB3A3B6-FF3D-4788-A142-EE2813A64EBC

Q43169344-3B65ED32-41F7-404F-9FAD-A7C3D01F0DB7

Q43169344-475DB5DA-8440-4795-B180-631B76B7AE06

Q43169344-8F043C65-D875-4C85-B14F-961D24DA5D83

Q43169344-95C320E2-DA3E-42EE-9E39-080AE9E9B27E

Q43169344-C01E6409-BB7F-4A5C-963E-C3D97E026365

Q43169344-F0150D6A-24D2-481B-9B33-9CEAA50BB44C

P2860

Q43169344-14FF4A3F-8D27-4579-980A-C81AC90E0319

Q43169344-1EED2E7A-12DD-4BAC-B4F8-A2B120A3FC74

Q43169344-2940F7B8-D706-404D-A3E7-2D5DBD3A6E4F

Q43169344-2DE91723-753A-4AB5-A769-89BD51CA1193

Q43169344-3A6957E8-74DA-47CB-8CC2-71B319EABDC9

Q43169344-405FF3E5-B7D2-46B3-BDD7-61741A05E96E

Q43169344-40E257BA-7DCB-4FFC-92AD-EE7AF505E451

Q43169344-45F69EEB-063B-4F64-AAA4-0266C91DECD0

Q43169344-496EF31A-39EF-41F8-82EE-47D1C526F356

Q43169344-4BF499D7-31C3-438D-BBFB-6BA81909D806

P2888

Q43169344-107BB9E0-EF7C-4764-8369-8209977CF9B0

P304

Q43169344-E277F15A-163F-48E8-9617-8444B4AB0F93

P31

Q43169344-948E1EA4-5EC1-4694-854E-5F8D39D284B5

P356

Q43169344-31C4D8BA-267D-4F98-B8D7-54F4E0427772

P433

Q43169344-779CEA13-3DA8-4FDA-A92F-A17C8A6F1E2E

P478

Q43169344-05192465-4475-4F6F-96D1-0059B03B175E

P50

Q43169344-FE0235D1-D8E3-4083-9162-7B3387E39573

P577

Q43169344-3C94D98E-64E7-4A4A-A26D-9265717371D8

P5875

Q43169344-8CAA2BD9-708D-47E5-86FE-9B3F737D031A

P6179

Q43169344-7FA2AEC2-470C-466F-B443-C2D7F5A6808F

P698

Q43169344-CBD4AA3E-5FA2-4661-9901-EC33FBADDC98

P921

Q43169344-9FB808EF-41AD-4906-9E79-3DFEE940478F

P356

P1433

Cancer Gene Therapy

P1476

Transcription-targeted gene therapy for androgen-independent prostate cancer.

@en

P2093

Diana E Brookes

http://www.w3.org/2001/XMLSchema#string

Dorethea Zandvliet

http://www.w3.org/2001/XMLSchema#string

Gerald W Both

http://www.w3.org/2001/XMLSchema#string

Linda J Lockett

http://www.w3.org/2001/XMLSchema#string

Pamela J Russell

http://www.w3.org/2001/XMLSchema#string

Peter Russell

http://www.w3.org/2001/XMLSchema#string

Rosetta Martiniello-Wilks

http://www.w3.org/2001/XMLSchema#string

Tania Tsatralis

http://www.w3.org/2001/XMLSchema#string

P2860

Dressing up adenoviruses to modify their tropism.. Interview by Florence Paillard.

In situ gene therapy for adenocarcinoma of the prostate: a phase I clinical trial.

Gene therapy for prostate cancer. New perspectives on an old problem.

Prodrug activation enzymes in cancer gene therapy.

Cancer statistics, 1998.

Manipulation of adenovirus vectors.

Large fragment of the probasin promoter targets high levels of transgene expression to the prostate of transgenic mice.

Prostate-specific antigen expression is regulated by an upstream enhancer.

A tissue-specific enhancer of the prostate-specific membrane antigen gene, FOLH1.

In vivo gene therapy for prostate cancer: preclinical evaluation of two different enzyme-directed prodrug therapy systems delivered by identical adenovirus vectors.

P2888

P304

443-452

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.CGT.7700451

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11405349

http://www.w3.org/2001/XMLSchema#string

P6179

1008092057

http://www.w3.org/2001/XMLSchema#string

P698

11961667

http://www.w3.org/2001/XMLSchema#string

P921